News
DNA-Technology has been developing, producing and introducing to laboratories high-tech equipment and kits for PCR (polymerase chain reaction) analysis since 1993.
main new
News
-
TELEGRAM CHANNEL OF DNA-TECHNOLOGY COMPANY
Subscribe to our channels.
Stay updated on company news, latest developments, and events. -
Press tour of the production facility
DNA-Technology, a Russian developer and manufacturer of molecular diagnostic solutions, hosted a delegation of representatives from government and scientific institutions of the Republic of India.
The visit took place in early July at the company's production facility as part of the development of bilateral cooperation.
The Indian delegation, which included representatives from the Ministry of Commerce and Industry of India, the Council of Scientific and Industrial Research (CSIR), the Invest India agency, and the Indian Embassy in the Russian Federation, showed particular interest in the company's production capacities, its product range, and the potential for collaboration in the fields of molecular diagnostics and biotechnology.
The high level of interest from Indian partners confirms the demand for Russian innovations and opens new horizons for joint projects.
This visit was a logical continuation of the work of the 9th meeting of the Russian-Indian Working Group on Priority Investment Projects (Moscow, July 3, 2026), following which the company's project was included in the List of Priority Russian-Indian Investment Projects.
The delegation's visit clearly demonstrates the need to deepen technological cooperation between the countries and strengthen strong business ties, and also lays the groundwork for new scientific, technical, and investment initiatives.
-
WHX BANGKOK 2026 HIGHLIGHTS
From July 8–10, DNA-Technology successfully completed its participation in WHX Bangkok 2026 — the largest industry forum in Southeast Asia.
Three days of intensive work, dozens of business meetings, and most importantly — a clear confirmation of our strategic direction: our presence in the region has become systematic. We came not just to present our products — we came to solidify our market position. And the results have exceeded our expectations.
-
DTstream stations and DTprime II Real-Time PCR Systems received high appreciation from representatives of major laboratory networks.
-
PCR reagent portfolio — we have confirmed that our product range fully addresses the requirements of regional laboratories.
We are especially proud that our booth was awarded the Sustainability Booth Design Award — Best of Show!
We were particularly pleased to observe strong brand loyalty toward DNA-Technology across Southeast Asia. We are recognized, trusted, and — importantly — recommended to professional peers. This serves as the highest validation of our commitment to quality and service excellence.
We extend our gratitude to all who visited our booth!
Meaningful engagement, expert discussions, and genuine interest inspire us to continue driving innovation.
-
-
DNA-Technology on KIHE-2026
May 20–22, 2026 – The 31st Kazakhstan International Healthcare Exhibition KIHE 2026 took place in Almaty. It is the largest platform in Central Asia for showcasing achievements in scientific and practical medicine.
The exhibition featured 400 companies from 16 countries. 37% of the stands were from Kazakh manufacturers, and 63% from international companies. The exposition was visited by 4,970 unique specialists: heads of medical centers, chief physicians, pharmacists, and doctors of various specialties.
Special attention was given to reproductive health – one of the key topics in modern medicine.
The demand for accurate and timely diagnostics, which help preserve patients’ reproductive potential and increase treatment effectiveness, is growing every year.
DNA -Technology company traditionally presented its advanced diagnostic solutions in this field at KIHE 2026.
We showcased our products for assessing the reproductive health of both men and women.
A report titled “New Diagnostic Capabilities in Reproductive Medicine” was delivered by Prof. N.Katkova, MD, PhD, which sparked great interest among the professional community.
The company’s portfolio includes a broad range of test systems for diagnostics in this area, including detection of:
-
Urogenital infections.
-
Human papillomavirus (HPV) infections.
-
Unique microbiota test systems: ANDROFLOR® (for men) and FEMOFLOR® (for women).
The visitors’ interest in microbiota research was very high, and our developments in this area are more relevant than ever.
Understanding the state of microbiota is essential for diagnosing inflammatory processes, fertility disorders, and preparing for assisted reproductive technologies.
We held productive meetings with partners, set goals, and discussed future collaboration plans.
-
-
10 years of partnership, trust and joint development
DNA‑Technology and the ITGEL Erüül Mend Clinic (Ulaanbaatar) have been working together for over a decade, advancing modern molecular diagnostics technologies in Mongolia.
Over this period, our collaboration has evolved from implementing the first PCR solutions to fully automating laboratory processes. Today, the clinic successfully operates a DNA‑Technology equipment suite, which includes several DTstream automated stations for nucleic acid extraction and PCR setup, as well as a high‑throughput DTprime II Real-Time PCR Systems in a 384‑well format.
The introduction of automation has significantly boosted the laboratory’s productivity, reduced the impact of human factors, and ensured high accuracy and reproducibility of results in daily diagnostic practice.
It is especially important for us that the equipment is not just installed but is actively used by the clinic’s specialists in routine work, helping doctors obtain reliable results faster and make timely clinical decisions.
We sincerely thank the team of the ITGEL Erüül Mend Clinic for their long‑term trust, professionalism and openness to adopting cutting‑edge technologies. Over the years, we have not only built a partnership but also created a solid foundation for further joint development.
We are confident that new projects, new technological solutions and new achievements in the field of modern laboratory diagnostics await us ahead.